FDA Drug Recalls

1,018 recalls, newest first

Jun 30, 2022 Class II · Moderate risk

Ketamine HCl Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1260-2022

Jun 30, 2022 Class II · Moderate risk

Ketamine HCl Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1259-2022

Jun 30, 2022 Class II · Moderate risk

HYDROmorphone HCl Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1258-2022

Jun 30, 2022 Class II · Moderate risk

HYDROmorphone HCl Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1257-2022

Jun 30, 2022 Class II · Moderate risk

HYDROmorphone HCl Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1256-2022

Jun 30, 2022 Class II · Moderate risk

HYDROmorphone HCl Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1255-2022

Jun 30, 2022 Class II · Moderate risk

Glycopyrrolate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1254-2022

Jun 30, 2022 Class II · Moderate risk

Glycopyrrolate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1253-2022

Jun 30, 2022 Class II · Moderate risk

Fentanyl Citrate in 0.9% Sodium Chloride Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1252-2022

Jun 30, 2022 Class II · Moderate risk

EPINEPHrine Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1251-2022

Jun 30, 2022 Class II · Moderate risk

EPINEPHrine Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1250-2022

Jun 30, 2022 Class II · Moderate risk

Bupivacaine HCl 150 mg

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1249-2022

Jun 30, 2022 Class II · Moderate risk

0.9% Buffered Lidocaine HCl

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1248-2022

Jun 30, 2022 Class II · Moderate risk

0.125% Bupivacaine HCl Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1247-2022

Jun 30, 2022 Class II · Moderate risk

Atropine Sulfate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1246-2022

Jun 30, 2022 Class II · Moderate risk

Amino Acid Injection 50 g/1000 mL

Lack of Assurance of Sterility

Terminated Sterility / contamination Nephron Sterile Compounding Center LLC D-1245-2022

Jun 29, 2022 Class II · Moderate risk

Alcohol Swabsticks

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 67777-300-01 D-1327-2022

Jun 29, 2022 Class II · Moderate risk

Sterile Alcohol Prep Pads

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 67777-121-16 D-1326-2022

Jun 29, 2022 Class II · Moderate risk

Racepinephrine Inhalation Solution

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-5901-99 D-1325-2022

Jun 29, 2022 Class II · Moderate risk

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-2784-01 D-1324-2022

Jun 29, 2022 Class II · Moderate risk

Dakin's Solution

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0436-0672-16 D-1323-2022

Jun 29, 2022 Class II · Moderate risk

A&D Original Ointment

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 11523-0096-3 D-1322-2022

Jun 29, 2022 Class II · Moderate risk

Pataday

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-8150-01 D-1321-2022

Jun 29, 2022 Class II · Moderate risk

GenTeal Tears

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0518-01 D-1320-2022

Jun 29, 2022 Class II · Moderate risk

Miralax (Polyethylene Glycol 3350)

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 11523-7234-4 D-1319-2022

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061